Abrocitinib bests placebo for treatment of atopic dermatitis

(HealthDay)—For moderate-to-severe atopic dermatitis, the oral Janus kinase 1 (JAK1) inhibitor abrocitinib at 200 mg or 100 mg once daily results in significantly greater reductions in signs and symptoms versus placebo, ...

Oncology & Cancer

Cancer patients can now use skin creams during radiation therapy

Contrary to the advice most cancer patients receive when they go through radiation treatment, topical skin treatments, unless applied very heavily, do not increase the radiation dose to the skin and can be used in moderation ...

Diseases, Conditions, Syndromes

The power of the Internet: It helps improve teens' acne

Tech-savvy teens with acne used their medicine more frequently when they also took part in a web-based survey, a new study from Wake Forest Baptist Medical Center finds.